HIMSS 2026 marked a quiet but meaningful shift in how the future of healthcare is being discussed. The debate is no longer centered on whether advanced automation will influence healthcare operations. That question has largely been settled. The more consequential issue now is how responsibility, coordination, and accountability are allocated as decision making becomes faster, more distributed, and more interconnected.
For payers, this shift carries particular weight.
Providers arrived at HIMSS with stories of streamlined clinical workflows. Technology vendors emphasized new tools designed to support clinical and administrative tasks. Payers, by contrast, confront a more structural problem. They must operate across fragmented data sources, layered regulation, and complex relationships with providers, pharmacies, and vendors. Progress depends less on adopting individual tools and more on reshaping how work is coordinated across the system.
Automation itself is not new to payers. Claims adjudication, utilization management, eligibility checks, and quality measurement have long relied on rules and logic embedded in large operational systems. These approaches were designed to answer specific questions efficiently and consistently. Is a service covered. Does a member meet criteria. Has a requirement been satisfied.
What is changing is the scope of the questions being asked.
Increasingly, payer organizations are being pushed toward decisions about sequence and coordination rather than eligibility alone. What should happen next. Who should be engaged. How should actions be aligned across organizations that do not share systems, incentives, or timelines. This represents a shift from passive processing toward active coordination.
The most notable signal from HIMSS was not a particular product announcement. It was the renewed emphasis on open and composable approaches to interoperability. Rather than embedding logic deeply within a single platform, these approaches allow intelligence and workflow coordination to operate between systems.
For payers, this is not an abstract architectural preference. Unlike providers or consumer technology companies, payers rarely control the primary systems through which care is delivered or accessed. They do not own the electronic health record. They do not manage most clinical workflows. They are often absent from the patient’s day‑to‑day digital experience. Any operating model that depends on control of a single platform is therefore unlikely to scale.
This reality is particularly evident in environments that span multiple vendors, delegated risk arrangements, and diverse lines of business such as employer plans, Medicare, and Medicaid. Coordination in these settings depends less on ownership and more on the ability to move decisions, context, and intent across organizational boundaries.
Interoperability, in this sense, is no longer simply about moving data. It is about enabling decisions to travel with that data and to trigger appropriate action.
Payers do not need sweeping transformation programs to respond. The more credible path forward is incremental but deliberate. Early progress is likely to come from narrow, high‑impact domains where coordination failures are costly and visible. Investment priorities are shifting toward pairing interoperability with decision logic, rather than treating them as separate concerns. At the same time, payer leaders are becoming more explicit about the need for transparency, control, and adaptability in the tools they adopt.
HIMSS did not offer a finished model for payer transformation. What it did provide was clarity about direction.
For much of the past decade, payer innovation has focused on quality programs, performance measurement, and internal efficiency. These efforts have delivered measurable improvements, particularly in areas such as Star Ratings and compliance. They have also reinforced an operating model in which analysis and identification of gaps are prioritized, while execution is often left to downstream partners.
That model is increasingly under strain.
Interoperability initiatives such as TEFCA and the growth of national data networks are reshaping expectations. These efforts are no longer viewed solely as regulatory requirements or technical infrastructure. They are increasingly framed around patient access, understanding, and participation. Payer engagement has historically been uneven, not because of lack of interest, but because the benefits were defined narrowly. That framing is beginning to change as the connection between data access and coordinated action becomes clearer.
At the same time, expectations are rising around how technology should support patients more directly. The focus is shifting from retrospective analysis toward real‑time prioritization and follow‑through. The emphasis is less on identifying gaps and more on ensuring that those gaps are addressed in a timely and coordinated way.
Pharmacy occupies a central position in this transition.
For many patients, interactions with the healthcare system are sporadic. Primary care visits may occur annually. Specialist care often begins after conditions have progressed. Pharmacists, by contrast, engage patients frequently through refills, immunizations, medication counseling, and chronic disease support. In practice, they often represent the most consistent point of contact in a patient’s healthcare experience.
This regular engagement positions pharmacy as a practical anchor for more coordinated, patient‑centered care. When pharmacists have access to timely and relevant context, they are better able to prioritize outreach, reinforce care plans, and coordinate with providers. The goal is not to replace professional judgment, but to support it with clearer signals and better alignment across the care team.
Taken together, these developments point to a broader shift in the payer operating model.
Interoperability is no longer just about making information available. Patient engagement is no longer limited to access alone. And automation is no longer confined to back‑office efficiency. The convergence of these forces is pushing payers toward a more active role as coordinators of outcomes, responsible for ensuring that information, decisions, and actions remain aligned across a fragmented system.
HIMSS 2026 suggested that future success will not be determined by who owns the most data or deploys the most tools. It will depend on who can coordinate care most effectively across organizational boundaries, with patients and pharmacists playing a more central role.
That future is still taking shape. But its direction is now difficult to ignore.